These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 31180016)
1. Health care: conflicted, confused, and in need of change. McCartney M; Heneghan C; Finnikin S Lancet; 2019 Jun; 393(10188):2281-2283. PubMed ID: 31180016 [No Abstract] [Full Text] [Related]
2. Conflict of interest in industry-sponsored drug development. Emanuel EJ Clin Adv Hematol Oncol; 2007 Apr; 5(4):265-7. PubMed ID: 17607285 [No Abstract] [Full Text] [Related]
3. [For and against: does sponsoring impede the growth of knowledge in medicine?]. Finzen A; Fritze J Psychiatr Prax; 2007 May; 34(4):162-4. PubMed ID: 17520527 [No Abstract] [Full Text] [Related]
4. Is industry money the root of all conflicts of interest in biomedical research? Caplan AL Ann Emerg Med; 2012 Feb; 59(2):87-8. PubMed ID: 21459479 [No Abstract] [Full Text] [Related]
5. More regulation of industry-supported biomedical research: are we asking the right questions? Fry-Revere S; Malmstrom DB J Law Med Ethics; 2009; 37(3):420-30, 395. PubMed ID: 19723253 [TBL] [Abstract][Full Text] [Related]
6. Dangerous liaisons? Industry relations with health professionals. Sade RM J Law Med Ethics; 2009; 37(3):398-400. PubMed ID: 19723250 [No Abstract] [Full Text] [Related]
7. Academic neurology and industry: open doors or firewalls? Griffin JW Nat Clin Pract Neurol; 2007 Jun; 3(6):297. PubMed ID: 17549056 [No Abstract] [Full Text] [Related]
8. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward. Samson K Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337 [No Abstract] [Full Text] [Related]
10. [Reflections on the relationship between the academic physician, the society in general and producing companies of drugs and equipment in particular]. Marin-Neto JA; Maciel BC Arq Bras Cardiol; 2005 Feb; 84(2):188-91. PubMed ID: 15761649 [No Abstract] [Full Text] [Related]
11. Medicine and the pharmaceutical industry. Baxter P Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771 [No Abstract] [Full Text] [Related]
12. Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective. Norris RA Curr Med Res Opin; 2010 Jul; 26(7):1675-6. PubMed ID: 20450261 [No Abstract] [Full Text] [Related]
13. Conflicts of interest. A golden standard to generalize in addiction research. Gual A Addiction; 2010 Feb; 105(2):199-200; author reply 205-6. PubMed ID: 20078473 [No Abstract] [Full Text] [Related]
14. Industry and medicine: conflicting interests and the power of money. Popovsky MA; Garcia N Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103 [No Abstract] [Full Text] [Related]
15. Medical ethics, research and the pharmaceutical industry. Abud-Mendoza C Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694 [No Abstract] [Full Text] [Related]
16. Editorial policies on financial disclosure. Jacobson MF; Sharpe VA; Angell M; Ashford NA; Blum A; Chary LK; Cho M; Coull BC; Davis D; Doolittle RF; Egilman D; Epstein SS; Greenberg M; Hooper K; Huff J; Joshi TK; Krimsky S; LaDou J; Levenstein C; Miles S; Needleman H; Pellegrino ED; Ravanesi B; Sass J; Schecter A; Schneiderman JS; Schubert D; Soffritti M; Suzuki D; Takaro TK; Temple NJ; Terracini B; Thompson A; Wallinga D; Wing S Nat Neurosci; 2003 Oct; 6(10):1001. PubMed ID: 14513030 [No Abstract] [Full Text] [Related]
18. Conflicts of interest and access to information from medical research. Byk C Bull Med Ethics; 2002 Apr; (177):18-9. PubMed ID: 12691105 [No Abstract] [Full Text] [Related]